Letter to the Editor: "Use of biomarkers to identify new drug targets and to predict risk of cardiometabolic outcomes" by Holmegard HN, et al. (2016)
Attributed to:
Aetiology of type 2 diabetes and related metabolic disorders
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1210/jc.2015-4111
PubMed Identifier: 26840109
Publication URI: http://europepmc.org/abstract/MED/26840109
Type: Journal Article/Review
Volume: 101
Parent Publication: The Journal of clinical endocrinology and metabolism
Issue: 2
ISSN: 0021-972X